[{"address1": "890 Winter Street", "address2": "Suite 200", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "781 208 2466", "website": "https://upstreambio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 clinical development for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps, and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 52, "companyOfficers": [{"maxAge": 1, "name": "Dr. E. Rand Sutherland M.D., M.P.H.", "age": 54, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 869154, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael Paul Gray CPA, MBA", "age": 53, "title": "CFO & COO", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 607200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Allison C. Ambrose J.D.", "age": 39, "title": "Senior VP, General Counsel & Secretary", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 59792, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stacy  Price M.S., P.M.P.", "age": 55, "title": "Chief Technology Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Meggan  Buckwell", "title": "Director of Corporate Communications & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Fiering", "title": "Senior Vice President of People & Culture", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Adam  Houghton M.B.A., Ph.D.", "age": 54, "title": "Chief Business Officer", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Aaron  Deykin M.D.", "age": 57, "title": "Chief Medical Officer and Head of Research & Development", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 736700, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mersedeh  Miraliakbari Pharm.D.", "title": "Senior Vice President of Regulatory Affairs & Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Fang  Xie Ph.D.", "title": "VP & Head of Biometrics", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 5, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 27.47, "open": 28.0, "dayLow": 26.78, "dayHigh": 28.25, "regularMarketPreviousClose": 27.47, "regularMarketOpen": 28.0, "regularMarketDayLow": 26.78, "regularMarketDayHigh": 28.25, "payoutRatio": 0.0, "forwardPE": -8.564972, "volume": 301224, "regularMarketVolume": 301224, "averageVolume": 443069, "averageVolume10days": 462060, "averageDailyVolume10Day": 462060, "bid": 20.16, "ask": 34.56, "bidSize": 2, "askSize": 2, "marketCap": 1466607360, "fiftyTwoWeekLow": 5.14, "fiftyTwoWeekHigh": 33.0, "allTimeHigh": 33.0, "allTimeLow": 5.14, "priceToSalesTrailing12Months": 523.97546, "fiftyDayAverage": 24.0115, "twoHundredDayAverage": 14.867325, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1095599360, "profitMargins": 0.0, "floatShares": 34181030, "sharesOutstanding": 54038591, "sharesShort": 2773635, "sharesShortPriorMonth": 2929476, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.0513, "heldPercentInsiders": 0.14773, "heldPercentInstitutions": 0.87456, "shortRatio": 6.4, "shortPercentOfFloat": 0.0925, "impliedSharesOutstanding": 54038591, "bookValue": 7.011, "priceToBook": 3.8710597, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -135815008, "trailingEps": -6.4, "forwardEps": -3.16872, "enterpriseToRevenue": 391.425, "enterpriseToEbitda": -7.807, "52WeekChange": 0.4450289, "SandP52WeekChange": 0.13613915, "quoteType": "EQUITY", "currentPrice": 27.14, "targetHighPrice": 75.0, "targetLowPrice": 35.0, "targetMeanPrice": 47.0, "targetMedianPrice": 42.5, "recommendationMean": 1.28571, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 372427008, "totalCashPerShare": 6.892, "ebitda": -140332000, "totalDebt": 1419000, "quickRatio": 31.469, "currentRatio": 32.669, "totalRevenue": 2799000, "debtToEquity": 0.375, "revenuePerShare": 0.054, "returnOnAssets": -0.28152, "returnOnEquity": -0.408, "grossProfits": 2799000, "freeCashflow": -87004000, "operatingCashflow": -122256000, "revenueGrowth": 0.125, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -55.39385, "financialCurrency": "USD", "symbol": "UPB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Upstream Bio, Inc.", "longName": "Upstream Bio, Inc.", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 443069, "fiftyTwoWeekLowChange": 22.0, "fiftyTwoWeekLowChangePercent": 4.2801557, "fiftyTwoWeekRange": "5.14 - 33.0", "fiftyTwoWeekHighChange": -5.8600006, "fiftyTwoWeekHighChangePercent": -0.17757578, "fiftyTwoWeekChangePercent": 44.50289, "earningsTimestamp": 1762349400, "earningsTimestampStart": 1762349400, "earningsTimestampEnd": 1762349400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -6.4, "epsForward": -3.16872, "epsCurrentYear": -2.5853, "priceEpsCurrentYear": -10.497814, "fiftyDayAverageChange": 3.1285, "fiftyDayAverageChangePercent": 0.13029175, "twoHundredDayAverageChange": 12.272675, "twoHundredDayAverageChangePercent": 0.8254797, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "corporateActions": [], "postMarketTime": 1765575620, "regularMarketTime": 1765573201, "exchange": "NMS", "messageBoardId": "finmb_1773603947", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.20131, "regularMarketPrice": 27.14, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1728653400000, "postMarketChangePercent": 0.0, "postMarketPrice": 27.14, "postMarketChange": 0.0, "regularMarketChange": -0.33, "regularMarketDayRange": "26.78 - 28.25", "displayName": "Upstream Bio", "trailingPegRatio": null, "__fetch_time": "2025-12-13"}]